Lintlha ka Tivicay (dolutegravir)

Meriana ea HIV e susumelitsoe ho Khetha Khetho ea Pele ho US

Tivicay (dolutegravir) ke setho sa integrase-inhibitor -sehlopheng sa li - antiretroviral se sebelisoang ho phekola HIV. E ne e le ea bobeli sehlopheng sa integrase inhibitors ho amoheloa ke US Food and Drug Administration (FDA).

Tivicay o ile a fuoa tumello ea li-FDA ka la 12 August, 2013, bakeng sa ho sebelisoa ho batho ba baholo hammoho le bana ba lilemo li 12 ho feta kapa ho feta ba boima ba lithane tse 40 (40kg) 'me ha ba e-s'o tšoaroe ka pele ka integrase inhibitor.

(Hona joale Tivicay ha e amohelehe bakeng sa bana ba ka tlase ho lilemo tse 12 le hoja liteko tsa meriana ea Phase III li ntse li tsoela pele ho hlahloba tšireletseho le katleho ea eona sehlopheng seo sa lilemo.)

Tivicay e boetse e le karolo ea lithethefatsi tse kileng tsa e-ba le letsatsi le leng le le leng, tse sebelisitsoeng hantle , Triumeq , tse akarelletsang meriana ea abacavir le lamivudine. Triumeq e ile ea amoheloa ke FDA ka la 22 August, 2014.

Lintlha-khōlō tsa Phuputso ea Bongaka

Thuto ea VIKING-3 e bontšitse hore Tivicay e ne e sebetsa ho 63% ea bakuli ba baholo ba hanyetsanang le lihlopha tse ngata tsa lithethefatsi tsa HIV, ho akarelletsa le integrase inhibitors Isentress (ratelgravir) le elvitegravir (e fumanoang piliseng e le 'ngoe, tekanyo ea tekanyo e kopanetsoeng ea lithethefatsi, Stribild ) .

Thuto ea SINGLE e senoletse hore bakuli ba Tivicay ba ne ba e-na le khaello e fokolang ea ho khaotsa ka lebaka la liphello tse mpe tsa lithethefatsi ho feta Atripla (tenofovir + emtricitabine + efavirenz). Ka mor'a libeke tse 48, lihlooho tse 2% tse fanoeng ka taolo ea Tivicay e fokotsoe kalafo ho fapana le 10% ea ba fumanang Atripla.

Tekanyo

Ho feta moo, bakeng sa bana ba tšehetsoeng ke Sustiva (efavirenz), Aptivus (tipranavir) + Norvir (ritonavir), Lexiva (fosamprenavir) + Norvir (ritonavir), kapa rifampin, tefo ea Tivicay e 50mg, habeli ka letsatsi.

Ha e e-s'o tsejoe haeba Tivicay e atleha ho bana ba nang le ts'oaetso e amanang le integrase inhibitor.

Tsamaiso ea lithethefatsi

Tivicay e ka nkoa ka ntle kapa e se na lijo, le ka nako efe kapa efe ea letsatsi.

Liphello tse Tloaelehileng

Litla-morao tse tloaelehileng ka ho fetisisa (tse hlahang ka 2% kapa tse ka tlaase ho linyeoe) ke:

Litšebelisano le lithethefatsi kapa ho se lumellane

Tikosyn (dofetilide), e sebelisetsoang ho phekola arrhythmia (ho sa tloaelehe ha pelo), e hanyetsanoa bakeng sa ho sebelisoa le Tivicay.

E le ho qoba ho sebelisana ha lithethefatsi le lithethefatsi, eletsa ngaka ea hau hore na o noa meriana e fe kapa e meng:

Tlhokomelo

> Mehloli:

Laebrari ea Sechaba ea Meriana ea US. "Letlapa la TIVICAY (dolutegravir sodium), filimi e koetsoe." Bethesda, Maryland; e ntlafalitsoeng ka August 2013.

ViiV Healthcare. "ViiV Healthcare e amohela tumello ea FDA bakeng sa Triumeq." London, Engelane; tokomane ea khatiso e fanoeng ka la 22 August 2014.

Walmsley S .; Antela, A .; Clumeck, N .; et al. "Dolutegravir (DTG; S / GSK1349572) + bacavir / lamivudine hang ha letsatsi le leng le le leng e bapisoa le tenofovir / emtricitabine / efavirenz: liphetho tsa libeke tse 48 - SINGLE (ING114467)." 52nd Interscience Conference mabapi le likokoana-hloko tsa antimicrobial le chemotherapy. San Francisco; La 9-12 September, 2012; Sephetho sa H-556b.

Nichols, G .; Grossberg, R .; Lazzarin, A .; et al. " Ho Etsa Likokoana-hloko tsa Dolutegravir ho Lihlooho le ho Hlōleha Setulong se thehiloeng ho Integrase Inhibitor: Beke ea 24 Sekhahla sa 3 se Tsoang ho VIKING-3." Kopano ea 11 ea Machaba ea Phekolo ea Meriana ho HIV Infection (HIV11). Glasgow, Scotland; La 11-15 November, 2012; Sekhetho O232.